Nymox Pharmaceutical Corporation (Nasdaq: NYMX) 28.8% HIGHER; announces successful new study results from the long-term blinded placebo crossover group from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE